journal article·2010-06

Human mesenchymal stem cells: Influence of oxygen pressure on proliferation and chondrogenic differentiation in fibrin glue in vitro

Laura Baumgartner, Stefan Arnhold, Klara Brixius, Klaus Addicks, Wilhelm Bloch

Publisher page

Abstract

Abstract Tissue engineering using biomaterials is a promising solution for cartilage replacement. The purpose of this study was to investigate whether the fibrin sealant Tissucol® provides a suitable scaffold for re‐implanting stem cells during chondrogenic replacement therapy. Pluripotent stem cells were isolated from adult human bone marrow (hMSCs), cultured and characterized by FACS (CD105+/CD106+, CD45‐/CD14‐/CD34‐). A large‐holed porous hMSC‐containing fibrin matrix was built that allowed hMSCs to survive throughout the period of culture (42 days) in either proliferation or chondrogenic differentiation medium under normoxic (21% O2) or hypoxic (3% O2) conditions. Morphology (as determined by electron microscopy) and proliferation (Ki67 staining) of the embedded hMSCs did not markedly vary under normoxic and hypoxic culture even after 42 days in culture. The stem cell marker Oct‐4 was expressed during the whole culture period. Under chondrogenic differentiation conditions, especially under hypoxic conditions, we observed rounded chondrocyte‐like cell types and a chondral phenotype assessed by mRNA expression of collagen II and Alcian blue staining. hMSCs seeded into large‐holed porous preparations of Tissucol® survive, proliferate and keep their stem cell character. Furthermore, culturing the cells in a corresponding medium induces chondrogenic differentiation, which could be remarkably and significantly enhanced under hypoxic conditions. © 2009 Wiley Periodicals, Inc. J Biomed Mater Res, 2010
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Mesenchymal stem cell research · Periodontal Regeneration and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (55)

Show source-provided references
1. 10.1016/0142-9612(96)85561-X10.1016/0142-9612(96)85561-X ↗
2. 10.1016/0092-8674(82)90027-710.1016/0092-8674(82)90027-7 ↗
3. 10.1097/01.BRS.0000048672.34459.3110.1097/01.BRS.0000048672.34459.31 ↗
4. 10.1089/ten.2006.12.158710.1089/ten.2006.12.1587 ↗
5. 10.1097/00006534-200003000-0001910.1097/00006534-200003000-00019 ↗
6. 10.1007/BF0155352310.1007/BF01553523 ↗
7. Human fibrin is a physiologic delivery system for bone morphogenetic protein10.1097/00003086-198810000-00031 ↗
8. 10.1055/s-0037-161338910.1055/s-0037-1613389 ↗
9. 10.1111/j.1432-0436.2004.07207003.x10.1111/j.1432-0436.2004.07207003.x ↗
10. 10.1089/ten.2005.11.119810.1089/ten.2005.11.1198 ↗
11. 10.1016/j.biomaterials.2006.08.02510.1016/j.biomaterials.2006.08.025 ↗
12. Bone marrow osteogenic stem cells: In vitro cultivation and transplantation in diffusion chambers
13. 10.1007/3-540-31265-X_1110.1007/3-540-31265-X_11 ↗
14. 10.1007/s00114-002-0344-910.1007/s00114-002-0344-9 ↗
15. 10.1089/ten.2005.11.156210.1089/ten.2005.11.1562 ↗
16. 10.1006/excr.1997.385810.1006/excr.1997.3858 ↗
17. 10.1089/ten.2004.10.169510.1089/ten.2004.10.1695 ↗
18. 10.1089/ten.2006.12.55910.1089/ten.2006.12.559 ↗
19. 10.1074/jbc.C60012020010.1074/jbc.C600120200 ↗
20. 10.1002/jcp.108110.1002/jcp.1081 ↗
21. 10.1016/j.ejcb.2005.06.00310.1016/j.ejcb.2005.06.003 ↗
22. 10.1016/j.ejcb.2006.01.01510.1016/j.ejcb.2006.01.015 ↗
23. 10.1073/pnas.14122169810.1073/pnas.141221698 ↗
24. 10.1002/jor.110009050410.1002/jor.1100090504 ↗
25. 10.1093/carcin/bgh32110.1093/carcin/bgh321 ↗
26. 10.1038/ng1101-24610.1038/ng1101-246 ↗
27. 10.1089/ten.2006.12.272910.1089/ten.2006.12.2729 ↗
28. 10.2741/302010.2741/3020 ↗
29. 10.1089/ten.2004.10.181810.1089/ten.2004.10.1818 ↗
30. 10.1016/j.biomaterials.2004.10.03710.1016/j.biomaterials.2004.10.037 ↗
31. 10.1016/j.joms.2006.11.04410.1016/j.joms.2006.11.044 ↗
32. 10.1002/bit.2025210.1002/bit.20252 ↗
33. 10.1002/jor.2046810.1002/jor.20468 ↗
34. 10.3727/00000000678398210610.3727/000000006783982106 ↗
35. 10.1021/bm060010d10.1021/bm060010d ↗
36. 10.1007/s10353-004-0115-210.1007/s10353-004-0115-2 ↗
37. 10.1016/S0006-3495(95)80327-910.1016/S0006-3495(95)80327-9 ↗
38. 10.1002/jcb.24045030610.1002/jcb.240450306 ↗
39. 10.1016/S0901-5027(05)80328-510.1016/S0901-5027(05)80328-5 ↗
40. 10.1097/00006534-199906000-0000110.1097/00006534-199906000-00001 ↗
41. 10.1007/s10237-006-0033-210.1007/s10237-006-0033-2 ↗
42. 10.1074/jbc.M50257320010.1074/jbc.M502573200 ↗
43. 10.1634/stemcells.2004-033010.1634/stemcells.2004-0330 ↗
44. 10.1002/jcb.2118510.1002/jcb.21185 ↗
45. 10.1634/stemcells.2007-035110.1634/stemcells.2007-0351 ↗
46. 10.1002/jcp.2057110.1002/jcp.20571 ↗
47. 10.1016/j.bbrc.2007.05.05410.1016/j.bbrc.2007.05.054 ↗
48. Observations on long bone medullary pressures in relation to arterial PO2. PCO2 and pH in the anaesthetized dog10.3109/17453677908991287 ↗
49. 10.3109/1745367850899435710.3109/17453678508994357 ↗
50. Cartilage tissue engineering: Controversy in the effect of oxygen10.1080/bty.23.3.175 ↗
51. 10.2106/00004623-197153040-0001110.2106/00004623-197153040-00011 ↗
52. Chondrocytes in the endochondral growth cartilage are not hypoxic10.1152/ajpcell.1997.272.4.C1134 ↗
53. 10.1038/190460a010.1038/190460a0 ↗
54. 10.1097/00000658-197204000-0002010.1097/00000658-197204000-00020 ↗
55. 10.1089/scd.2008.003010.1089/scd.2008.0030 ↗